Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
SUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,072328-   
Low Rs790236-   
Sales per share (Unadj.) Rs182.997.5-  
Earnings per share (Unadj.) Rs35.7-24.6-  
Cash flow per share (Unadj.) Rs46.2-20.4-  
Dividends per share (Unadj.) Rs11.500-  
Avg Dividend yield %1.20-  
Book value per share (Unadj.) Rs233.476.5-  
Shares outstanding (eoy) m2,399.34168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.12.9 175.9%   
Avg P/E ratio x26.1-11.5 -227.2%  
P/CF ratio (eoy) x20.1-13.9 -145.3%  
Price / Book Value ratio x4.03.7 108.2%  
Dividend payout %32.20-   
Avg Mkt Cap Rs m2,233,36147,604 4,691.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m82,9602,988 2,776.7%   
Avg. sales/employee Rs Th03,832.5-  
Avg. wages/employee Rs Th0696.0-  
Avg. net profit/employee Rs Th0-965.7-  
INCOME DATA
Net Sales Rs m438,85716,453 2,667.4%  
Other income Rs m8,199115 7,115.8%   
Total revenues Rs m447,05516,568 2,698.3%   
Gross profit Rs m112,900-2,851 -3,959.8%  
Depreciation Rs m25,294710 3,562.1%   
Interest Rs m1,720446 385.9%   
Profit before tax Rs m94,084-3,892 -2,417.6%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,476243 3,485.5%   
Profit after tax Rs m85,608-4,146 -2,065.0%  
Gross profit margin %25.7-17.3 -148.5%  
Effective tax rate %9.0-6.2 -144.2%   
Net profit margin %19.5-25.2 -77.4%  
BALANCE SHEET DATA
Current assets Rs m398,61912,050 3,308.0%   
Current liabilities Rs m199,0646,780 2,936.0%   
Net working cap to sales %45.532.0 142.0%  
Current ratio x2.01.8 112.7%  
Inventory Days Days147111 132.6%  
Debtors Days Days95124 76.8%  
Net fixed assets Rs m376,9607,024 5,366.7%   
Share capital Rs m2,39976 3,140.9%   
"Free" reserves Rs m557,5550-   
Net worth Rs m559,95412,914 4,336.1%   
Long term debt Rs m04,538 0.0%   
Total assets Rs m775,79424,395 3,180.1%  
Interest coverage x55.7-7.7 -720.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 83.9%   
Return on assets %11.3-15.2 -74.2%  
Return on equity %15.3-32.1 -47.6%  
Return on capital %17.1-19.8 -86.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m82,5410-   
CASH FLOW
From Operations Rs m49,5931,404 3,531.4%  
From Investments Rs m-79,437-431 18,421.9%  
From Financial Activity Rs m23,7614,119 576.9%  
Net Cashflow Rs m1,1555,092 22.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.52 Rs / ZAR

Compare SUN PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: TYCHE INDUSTRIES  NEULAND LABS  SOURCE NATURAL FOODS  PLETHICO PHARMA  ALCHEMIST LIMITED  



Today's Market

Gift Nifty Trades Flat | Why PSU Bank Stocks are Rising | Canara Bank Q4 Results | Top Buzzing Stocks Today Gift Nifty Trades Flat | Why PSU Bank Stocks are Rising | Canara Bank Q4 Results | Top Buzzing Stocks Today(Pre-Open)

Indian share markets pared losses as the session progressed but still ended lower.